Cefoxitin Effective For Treatment Of Patients With Urinary Tract Infection Caused By Extended-Spectrum β-Lactamase-Producing Escherichia Coli, Study Finds

November 08, 2022

Infectious Disease Advisor (11/7, Cimino) reports, “Cefoxitin is effective for the treatment of patients with urinary tract infection caused by extended-spectrum β-lactamase (ESBL)-producing Escherichia coli, with an optimal dose of 2 g every 6 hours via...